Mehr »
Dienstag, 22.05.2018 Börsentäglich über 12.000 News von 579 internationalen Medien



24 h / 7 T
7 Tage



24 h / 7 T
7 Tage








Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Ad hoc-Mitteilungen

WKN: A14RPH ISIN: US1638511089 Ticker-Symbol: 2CU 
S&P MidCap 400
CHEMOURS COMPANY 1-Woche-Intraday-Chart
15.02.2018 | 13:21
(7 Leser)
Schrift ändern:
(0 Bewertungen)


LONDON, UK / ACCESSWIRE / February 15, 2018 / Active-Investors.com has just released a free research report on Univar Inc. (NYSE: UNVR). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/'symbol=UNVR as the Company's latest news hit the wire. On February 13, 2017, the Company announced an exclusive distribution agreement with The Chemours Co. (NYSE: CC) for Hydrochloric Acid produced at Chemours' Parkersburg, West Virginia plant. Register today and get access to over 1,000 Free Research Reports by joining our site below:


Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Univar and Chemours most recent news is on our radar >and our team decided to put out a fantastic report on the company that is now available for free below:



About the Agreement

Hydrochloric Acid, with a total market of over five million tons, is widely used in a number of industrial applications, including pH control for water treatment processes, steel manufacturing, and oil and gas drilling. With this agreement, Univar would be able to bring this important product closer to its customers in these markets, shortening the supply chain and improving service response times.

Jerry Panock, Univar's Vice President of growth in the basic chemicals segment, said:

"Customers will benefit from Chemours and Univar's shared safety culture and focus on productivity and efficiency to help manage their cost to serve. Additionally, it will help provide customers with a competitive and long-term supply of Hydrochloric Acid, critical to their operations."

Back to Back Distribution Agreement

On February 12, 2018, Univar announced that it has reached a distribution agreement with ABITEC Corp. for its specialty lipids comprising of, CAPMUL, CAPTEX, CAPROL, ACCONON, STEROTEX, NUTRI SPERSE, HYRDO-KOTE, and PURECO product lines in Canada, effective February 01, 2018. In the pharmaceutical market, these products are used for a wide-array of applications including: solubilization, emulsification and lubrication to improve drug delivery and enhance bioavailability. In the nutraceutical market, these products are used in a number of health applications such as sports nutrition and performance as well as weight management.

Owned by Associated British Foods (ABF), ABITEC is a division of ABF Ingredients. Univar noted that the collaboration with ABITEC, will further enhance Univar's portfolio of highly-functional ingredients for the pharmaceutical and nutraceutical industries, both of which, the Company has identified as strategic growth industries for Univar.

Upcoming Earnings

On January 23, 2018, Univar announced that it will release its financial results for the fourth quarter and full year of fiscal 2017 on February 28, 2018, at approximately 6 a.m. EST. In conjunction with the release, the Company will host a webcast with investors to discuss the fourth-quarter and full-year results at 9:00 a.m. EST on February 28, 2018.

About Univar Inc.

Founded in 1924, Univar is a global chemical and ingredients distributor and provider of value-added services, working with leading suppliers worldwide. Supported by a comprehensive team of sales and technical professionals with deep specialty and market expertise, Univar operates hundreds of distribution facilities throughout North America, Western Europe, Asia-Pacific and Latin America. Univar delivers tailored customer solutions through a broad product and services portfolio sustained by one of the most extensive industry distribution networks in the world.

Stock Performance Snapshot

February 14, 2018 - At Wednesday's closing bell, Univar's stock slightly dropped 0.79%, ending the trading session at $27.67.

Volume traded for the day: 477.38 thousand shares.

Stock performance in the previous six-month period - up 2.52%

After yesterday's close, Univar's market cap was at $3.77 billion.

Price to Earnings (P/E) ratio was at 121.36.

The stock is part of the Basic Materials sector, categorized under the Chemicals - Major Diversified industry. This sector was up 2.0% at the end of the session.


Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.


For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors